Product image of Levetiracetam Altan (Levetiracetam) supplied by GNH India

Levetiracetam Altan

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Altan (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Altan, is an anticonvulsant presented as a pharmaceutical grade for intravenous and oral use. It is employed to manage various seizure types, including partial, generalized tonic‑clonic, and myoclonic seizures, in patients diagnosed with epilepsy. The molecule works by binding to synaptic vesicle protein SV2A, modulating neurotransmitter release and reducing neuronal excitability.

GNH India supplies Levetiracetam Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics, as well as specialized care centers, worldwide.

Manufacturer / TM Owner

Altan Pharmaceuticals S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an anticonvulsant used to treat epilepsy by stabilizing neuronal activity.

  • Partial seizures: reduces the frequency of focal onset seizures in patients with epilepsy.
  • Generalized tonic‑clonic seizures: helps control convulsive episodes across the whole brain.
  • Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with myoclonic epilepsy.

How It Works

  • Levetiracetam binds selectively to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates synaptic transmission, decreasing excessive neuronal firing and stabilizing neuronal excitability, which contributes to seizure control in various epilepsy syndromes.

Side Effects

Levetiracetam is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Somnolence: increased sleepiness or fatigue.
  • Headache: mild to moderate cranial pain.
  • Irritability: mood changes or increased agitation.
  • Nausea: upset stomach or feeling of queasiness.

Serious or Rare Side Effects

  • Severe allergic reactions: rash, swelling, or anaphylaxis.
  • Stevens‑Johnson syndrome: rare but serious skin disorder.
  • Blood dyscrasias: abnormal blood counts such as leukopenia.
  • Suicidal ideation: thoughts of self‑harm or depression.
  • Severe depression: marked mood disturbances requiring medical attention.

Precautions & Warnings

Before initiating therapy, consider the following precautions.

  • Renal impairment: assess kidney function and adjust dose if necessary.
  • Hepatic impairment: monitor liver enzymes and consider dose modification.
  • Psychiatric symptoms: observe for mood changes, depression, or suicidal thoughts.
  • Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare professional.
  • Concomitant CNS depressants: may increase sedation or respiratory depression.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Levetiracetam may interact with other medicines; review the following.

Major Interactions (Avoid)

  • Carbamazepine: can lower levetiracetam plasma concentrations.
  • Phenobarbital: may reduce levetiracetam levels, decreasing efficacy.
  • Phenytoin: can decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely)

  • Alcohol: additive central nervous system depression.
  • Other antiepileptic drugs: may require dose adjustments based on therapeutic response.
  • Renal excretion inhibitors: monitor renal function and consider dose changes.

Frequently Asked Questions

Levetiracetam Altan is used as an antiepileptic medication to control seizures. It is indicated for partial (focal) seizures, generalized tonic‑clonic seizures, and myoclonic seizures in patients diagnosed with epilepsy.

Levetiracetam binds to the synaptic vesicle protein SV2A, which regulates neurotransmitter release. This binding modulates synaptic transmission, reduces excessive neuronal firing, and stabilizes neuronal excitability, thereby helping to prevent seizure activity.

The dosage of Levetiracetam Altan is individualized. A qualified prescriber determines the appropriate dose based on the patient’s age, weight, renal function, seizure type, and response to therapy. No fixed regimen is provided here.

Levetiracetam’s pregnancy category is listed as unknown, and limited data are available for breastfeeding. Healthcare providers should evaluate the potential benefits against possible risks before prescribing to pregnant or nursing women.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It generally has fewer drug‑enzyme interactions, a favorable tolerability profile, and can be used as add‑on therapy, but individual response varies.

Store Levetiracetam Altan at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and avoid exposure to extreme temperatures to maintain stability.

Levetiracetam Altan can be given orally as tablets or solution, and intravenously as a sterile injection. The route and formulation are selected by the prescriber based on clinical need and patient suitability.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, blood dyscrasias, and psychiatric effects like suicidal thoughts or severe depression. Patients should be monitored closely for any of these signs and seek immediate medical attention if they occur.

Levetiracetam Altan is contraindicated in patients with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled psychiatric disorders, or those taking interacting medications listed under major interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT